Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the protective bioactivity and molecular mechanism verification of lactoferrin in an Alzheimer's mouse model with ulcerative enteritis

13 Mar 2024

Abstract excerpt

The development of new drug therapies for Alzheimer's disease (AD) is an important research topic today, but the pathogenesis of AD has not been thoroughly studied, and there are still several shortcomings in existing drug therapies. Therefore, this study aimed to explore the molecular mechanism of lactoferrin (LF) in the treatments of AD and ulcerative colitis (UC) that is susceptible to AD, starting from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Digestive system and related health
Share to Infant Nutrition and Health
Share to Pediatric Hepatobiliary Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38490542
DOI: 10.3168/jds.2024-24206

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the protective bioactivity and molecular mechanism verification of lactoferrin in an Alzheimer's mouse model with ulcerative enteritisPMID 38490542Read ↗

Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeuticsSemantic proximity Read ↗

Short-chain fatty acids: Important components of the gut-brain axis against ADSemantic proximity Read ↗

Association Between the Gut Microbiota and Alzheimer’s Disease: An Update on Signaling Pathways and Translational TherapeuticsSemantic proximity Read ↗

The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to TreatmentSemantic proximity Read ↗

Dietary Pattern, Gut Microbiota, and Alzheimer’s DiseaseSemantic proximity Read ↗

The Microbiome and Alzheimer’s Disease: Potential and Limitations of Prebiotic, Synbiotic, and Probiotic FormulationsSemantic proximity Read ↗

Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancerSemantic proximity Read ↗

Fecal microbiota transplantation: a novel strategy for treating Alzheimer’s diseaseSemantic proximity Read ↗

Next Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic PerspectiveSemantic proximity Read ↗

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer’s DiseaseSemantic proximity Read ↗

Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical ModelsSemantic proximity Read ↗

The role of gut microbiota in pathogenesis of Alzheimer's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.